METHOD OF TREATING EPILEPSIAS Russian patent published in 2015 - IPC A61K35/20 A61P25/08 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to psychiatrics and neurology, and concerns treating epilepsy. That is ensured by administering antiepileptic preparations and immunomodulators; the immunomodulators are presented by natural oral transfer factors 'Transfer Factor' or 'Transfer Factor Advanced'. The transfer factors are administered in age daily doses depending on the clinical encephalographic values: maximum dosages, namely: into the children under 3 years of age - 800-1,000 mg/day, 3-7 years old - 1,000-1,200 mg/ day, 7-10 years old - 1,200-1,500 mg/day, aged 10 years and older and adults - 1,500-1,800 mg/day, are indicated for the patients with the current epileptic process for 6 months after the last clinically recorded attack; moderate dosages, namely: into the children under 3 years of age - 600-800 mg/day, 3-7 years old - 800-1,000 mg/ day, 7-10 years old - 1,000-1,200 mg/day, aged 10 years and older and adults - 1,200-1,500 mg/day, are used if observing clinical remission min. 1 year long; the support dosages, namely: into the children under 3 years of age - 400-600 mg/day, 3-7 years old - 600-800 mg/ day, 7-10 years old - 800-1,000 mg/day, aged 10 years and older and adults - 1,000-1,200 mg/day are administered for 3 years; if observing long-lasting remission, seasonal course prevention is initiated in dosages into the children under 3 years of age - 200-400 mg/day, 3-7 years old - 400-600 mg/ day, 7-10 years old - 600-800 mg/day, aged 10 years and older and adults - 800-1,000 mg/day; the transfer factors in the maximum or moderate dosages are used in intercurrent diseases or psychophysical overloads.

EFFECT: method provides the effective treatment of various forms of epilepsias with reducing side effects and reducing doses of the antiepileptic preparations.

1 tbl, 4 ex